FdaApplication
NDA 022117
Identifiers
- fda_app_no: NDA022117
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2009-08-13 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAPHRIS | ASENAPINE MALEATE | EQ 10MG BASE | TABLET;SUBLINGUAL |
| SAPHRIS | ASENAPINE MALEATE | EQ 2.5MG BASE | TABLET;SUBLINGUAL |
| SAPHRIS | ASENAPINE MALEATE | EQ 5MG BASE | TABLET;SUBLINGUAL |
3 products